Press Releases

MALVERN, Pa., Sept. 4, 2019 /PRNewswire/ -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Greenbrook TMS, a NeuroStar Advanced Therapy provider with 82 treatment centers a

VANCOUVER, British Columbia, Sept. 4, 2019 /PRNewswire/ -- Natreve, the new premium wellness and supplement company, today announces its launch with the introduction of its line of real-food, highly

BREA, Calif., Sept. 4, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock.Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase up to

SANTA CLARA, Calif., Sept. 4, 2019 /PRNewswire/ -- The class of monoclonal antibody (mAb) therapeutics has grown considerably in the past two decades and now makes up a significant portion of the biotherapeutics market. Pharmaceutical manufacturing operations continue to adjust to the increasing demand, particularly around the processes of harvest, clarification, a

CHICAGO, Sept. 4, 2019 /PRNewswire/ -- Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-ene

NYSE | TSX : ACB EDMONTON, Sept. 4, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that on September 3, 2019, Aurora disposed of its remaining 28,833,334 shares, representing 10.5% of the issued and outstandin

BURLINGTON, ON, Sept. 4, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) announced today that th

SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that members of the management team will provide a business overview and update at

ROCKVILLE, Md. and ALPHARETTA, Ga., Sept. 4, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, and Clearside Biomedical, Inc. (Nasdaq: CLSD), a bio

PHILADELPHIA and BOSTON, Sept. 4, 2019 /PRNewswire/ -- Pareto Health, Inc. ("Pareto Health"), a leading employee benefit group captive manager that he